CRVS- Corvus Pharmaceuticals, Inc.

Name: Corvus Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Corvus Pharmaceuticals, Inc. (CRVS) has 8 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. CRVS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Orbimed Advisors LLC	8.34M	$99.35M	-
CEO	Miller Richard A Md	1.00M	$11.91M	-
Other	Jones William Benton	400.0K	$4.76M	-
CFO	Lea Leiv	400.0K	$4.76M	-
Other	Arcara Jeffrey	100.0K	$1.19M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 21, 2016	Orbimed Advisors LLC67	Director, 10% Owner	Buy	38,383	$12.75	$489,192.21	+0.4%
Jun 21, 2016	Thompson Peter A.65	Director, 10% Owner	Buy	38,383	$12.75	$489,192.21	+0.4%
Jun 16, 2016	Orbimed Advisors LLC67	Director, 10% Owner	Buy	20,000	$12.35	$247,000.00	+0.1%
Jun 16, 2016	Thompson Peter A.65	Director, 10% Owner	Buy	20,000	$12.35	$247,000.00	+0.1%
Jun 10, 2016	Orbimed Advisors LLC67	Director, 10% Owner	Buy	50,000	$12.96	$648,100.00	+0.5%
Jun 10, 2016	Thompson Peter A.65	Director, 10% Owner	Buy	50,000	$12.96	$648,100.00	+0.5%
May 20, 2016	Orbimed Advisors LLC67	Director, 10% Owner	Buy	4,716	$13.09	$61,732.44	-
May 20, 2016	Thompson Peter A.65	Director, 10% Owner	Buy	4,716	$13.09	$61,732.44	-
May 19, 2016	Thompson Peter A.65	Director, 10% Owner	Buy	6,800	$11.77	$80,035.04	-
May 19, 2016	Orbimed Advisors LLC67	Director	Buy	6,800	$11.77	$80,035.04	-

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC